-
1
-
-
0033824164
-
Mesenchymal stem cells: Biology and potential clinical uses
-
Deans RJ, Moseley AB. 2000. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 28:875-884.
-
(2000)
Exp Hematol
, vol.28
, pp. 875-884
-
-
Deans, R.J.1
Moseley, A.B.2
-
2
-
-
3142703230
-
Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells
-
Simmons CA, Alsberg E, Hsiong S, et al. 2004. Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. Bone 35:562-569.
-
(2004)
Bone
, vol.35
, pp. 562-569
-
-
Simmons, C.A.1
Alsberg, E.2
Hsiong, S.3
-
3
-
-
0025857671
-
Recombi-nant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro
-
Yamaguchi A, Katagiri T, Ikeda T, et al. 1991. Recombi-nant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J Cell Biol 113:681-687.
-
(1991)
J Cell Biol
, vol.113
, pp. 681-687
-
-
Yamaguchi, A.1
Katagiri, T.2
Ikeda, T.3
-
4
-
-
0027946689
-
Bone morphogenetic protein-2 converts the differentiation pathway of c2cl2 myoblasts into the osteoblast lineage
-
Katagiri T, Yamaguchi A, Komaki M, et al. 1994. Bone morphogenetic protein-2 converts the differentiation pathway of c2cl2 myoblasts into the osteoblast lineage. J Cell Biol 127:1755-1766.
-
(1994)
J Cell Biol
, vol.127
, pp. 1755-1766
-
-
Katagiri, T.1
Yamaguchi, A.2
Komaki, M.3
-
5
-
-
0031105160
-
Bone morphogenetic proteins: An unconventional approach to isolation of first mammalian morphogens
-
Reddi AH. 1997. Bone morphogenetic proteins: an unconventional approach to isolation of first mammalian morphogens. Cytokine Growth Factor Rev 8:11-20.
-
(1997)
Cytokine Growth Factor Rev
, vol.8
, pp. 11-20
-
-
Reddi, A.H.1
-
6
-
-
0027769670
-
Initiation and promotion of bone differentiation by bone morphogenetic proteins
-
Reddi AH Cunningham NS. 1993. Initiation and promotion of bone differentiation by bone morphogenetic proteins. J Bone Miner Res 8 (Suppl 2):S499-S502.
-
(1993)
J Bone Miner Res
, vol.8
, Issue.SUPPL. 2
-
-
Reddi, A.H.1
Cunningham, N.S.2
-
7
-
-
0028936897
-
Experimental studies on bone inducing activity of composites of atelopeptide type I collagen as a carrier for ectopic osteoinduction by rhBMP-2
-
Fujimura K, Bessho K, Kusumoto K, et al. 1995. Experimental studies on bone inducing activity of composites of atelopeptide type I collagen as a carrier for ectopic osteoinduction by rhBMP-2. Biochem Biophys Res Commun 208:316-322.
-
(1995)
Biochem Biophys Res Commun
, vol.208
, pp. 316-322
-
-
Fujimura, K.1
Bessho, K.2
Kusumoto, K.3
-
8
-
-
0032617215
-
Comparative study of intramuscular and intraskeletal osteogenesis by recombinant human bone morphogenetic protein-2
-
Okubo Y, Bessho K, Fujimura K, et al. 1999. Comparative study of intramuscular and intraskeletal osteogenesis by recombinant human bone morphogenetic protein-2. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 87:34-38.
-
(1999)
Oral Surg Oral Med Oral Pathol Oral Radiol Endod
, vol.87
, pp. 34-38
-
-
Okubo, Y.1
Bessho, K.2
Fujimura, K.3
-
9
-
-
0034134364
-
Osteoinduction by recombinant human bone morphogenetic protein-2 at intramuscular, intermuscular, subcutaneous and intra-fatty sites
-
Okubo Y, Bessho K, Fujimura K, et al. 2000. Osteoinduction by recombinant human bone morphogenetic protein-2 at intramuscular, intermuscular, subcutaneous and intra-fatty sites. Int J Oral Maxillofac Surg 29:62-66.
-
(2000)
Int J Oral Maxillofac Surg
, vol.29
, pp. 62-66
-
-
Okubo, Y.1
Bessho, K.2
Fujimura, K.3
-
10
-
-
27144471318
-
Repairing of goat tibial bone defects with BMP-2 gene-modified tissue-engineered bone
-
Dai KR, Xu XL, Tang TT, et al. 2005. Repairing of goat tibial bone defects with BMP-2 gene-modified tissue-engineered bone. Calcif Tissue Int 77:55-61.
-
(2005)
Calcif Tissue Int
, vol.77
, pp. 55-61
-
-
Dai, K.R.1
Xu, X.L.2
Tang, T.T.3
-
11
-
-
0028914687
-
Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: Comparisons between immunocompetent and immunodeficient inbred strains
-
Barr D, Tubb J, Ferguson D, et al. 1995. Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains. Gene Ther 2:151-155.
-
(1995)
Gene Ther
, vol.2
, pp. 151-155
-
-
Barr, D.1
Tubb, J.2
Ferguson, D.3
-
12
-
-
0029936764
-
Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors
-
Tripathy SK, Black HB, Goldwasser E, et al. 1996. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat Med 2:545-550.
-
(1996)
Nat Med
, vol.2
, pp. 545-550
-
-
Tripathy, S.K.1
Black, H.B.2
Goldwasser, E.3
-
13
-
-
0028328261
-
Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy
-
Yang Y, Nunes FA, Berencsi K, et al. 1994. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 91:4407-4411.
-
(1994)
Proc Natl Acad Sci USA
, vol.91
, pp. 4407-4411
-
-
Yang, Y.1
Nunes, F.A.2
Berencsi, K.3
-
14
-
-
0029836503
-
Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs
-
Yang Y, Su Q, Wilson JM. 1996. Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs. J Virol 70:7209-7212.
-
(1996)
J Virol
, vol.70
, pp. 7209-7212
-
-
Yang, Y.1
Su, Q.2
Wilson, J.M.3
-
15
-
-
0028484704
-
MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with El-deleted recombinant adenoviruses
-
Yang Y, Ertl HC, Wilson JM. 1994. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with El-deleted recombinant adenoviruses. Immunity 1:433-442.
-
(1994)
Immunity
, vol.1
, pp. 433-442
-
-
Yang, Y.1
Ertl, H.C.2
Wilson, J.M.3
-
16
-
-
0028934815
-
Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: Tolerization of factor IX and vector antigens allows for long-term expression
-
Dai Y, Schwarz EM, Gu D, et al. 1995. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proc Natl Acad Sci USA 92:1401-1405.
-
(1995)
Proc Natl Acad Sci USA
, vol.92
, pp. 1401-1405
-
-
Dai, Y.1
Schwarz, E.M.2
Gu, D.3
-
17
-
-
0029741231
-
Transient immunosuppression by FK506 permits a sustained high-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscles of adult dystrophic (mdx) mice
-
Lochmuller H, Petrof BJ, Pari G, et al. 1996. Transient immunosuppression by FK506 permits a sustained high-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscles of adult dystrophic (mdx) mice. Gene Ther 3:706-716.
-
(1996)
Gene Ther
, vol.3
, pp. 706-716
-
-
Lochmuller, H.1
Petrof, B.J.2
Pari, G.3
-
18
-
-
0033914913
-
Effect of p53 gene therapy combined with CTLA4Ig selective immunosuppression on prolonged neointima formation reduction in a rat model
-
Ascher E, Scheinman M, Hingorani A, et al. 2000. Effect of p53 gene therapy combined with CTLA4Ig selective immunosuppression on prolonged neointima formation reduction in a rat model. Ann Vasc Surg 14:385-392.
-
(2000)
Ann Vasc Surg
, vol.14
, pp. 385-392
-
-
Ascher, E.1
Scheinman, M.2
Hingorani, A.3
-
20
-
-
0025830902
-
CTLA-4 is a second receptor for the B cell activation antigen B7
-
Linsley PS, Brady W, Urnes M, et al. 1991. CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med 174:561-569.
-
(1991)
J Exp Med
, vol.174
, pp. 561-569
-
-
Linsley, P.S.1
Brady, W.2
Urnes, M.3
-
21
-
-
0031883333
-
Blunting of immune responses to adenoviral vectors in mouse liver and lung with CTLA4Ig
-
Jooss K, Turka LA, Wilson JM. 1998. Blunting of immune responses to adenoviral vectors in mouse liver and lung with CTLA4Ig. Gene Ther 5:309-319.
-
(1998)
Gene Ther
, vol.5
, pp. 309-319
-
-
Jooss, K.1
Turka, L.A.2
Wilson, J.M.3
-
22
-
-
0030847771
-
Constitutive expression of murine CTLA4Ig from a recombinant adenovirus vector results in prolonged transgene expression
-
Schowalter DB, Meuse L, Wilson CB, et al. 1997. Constitutive expression of murine CTLA4Ig from a recombinant adenovirus vector results in prolonged transgene expression. Gene Ther 4:853-860.
-
(1997)
Gene Ther
, vol.4
, pp. 853-860
-
-
Schowalter, D.B.1
Meuse, L.2
Wilson, C.B.3
-
23
-
-
0032587080
-
Adenoviral delivery of CTLA4Ig into myeloid dendritic cells promotes their in vitro tolerogenicity and survival in allogeneic recipients
-
Lu L, Gambotto A, Lee WC, et al. 1999. Adenoviral delivery of CTLA4Ig into myeloid dendritic cells promotes their in vitro tolerogenicity and survival in allogeneic recipients. Gene Ther 6:554-563.
-
(1999)
Gene Ther
, vol.6
, pp. 554-563
-
-
Lu, L.1
Gambotto, A.2
Lee, W.C.3
-
24
-
-
0030772479
-
CD28 blockade alters cytokine mRNA profiles in cardiac transplantation
-
Lin H, Wei RQ, Goodman RE, et al. 1997. CD28 blockade alters cytokine mRNA profiles in cardiac transplantation. Surgery 122:129-137.
-
(1997)
Surgery
, vol.122
, pp. 129-137
-
-
Lin, H.1
Wei, R.Q.2
Goodman, R.E.3
-
25
-
-
0038204193
-
Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide
-
Krampera M, Glennie S, Dyson J, et al. 2003. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 101:3722-3729.
-
(2003)
Blood
, vol.101
, pp. 3722-3729
-
-
Krampera, M.1
Glennie, S.2
Dyson, J.3
-
26
-
-
0032973123
-
Gene therapy: Adenovirus-mediated human bone morphogenetic protein-2 gene transfer induces mesenchymal progenitor cell proliferation and differentiation in vitro and bone formation in vivo
-
Lou J, Xu F, Merkel K, et al. 1999. Gene therapy: adenovirus-mediated human bone morphogenetic protein-2 gene transfer induces mesenchymal progenitor cell proliferation and differentiation in vitro and bone formation in vivo. J Orthop Res 17:43-50.
-
(1999)
J Orthop Res
, vol.17
, pp. 43-50
-
-
Lou, J.1
Xu, F.2
Merkel, K.3
-
27
-
-
0029150092
-
Growth of donor-derived dendritic cells from the bone marrow of murine liver allograft recipients in response to granulocyte/ macrophage colony-stimulating factor
-
Lu L, Rudert WA, Qian S, et al. 1995. Growth of donor-derived dendritic cells from the bone marrow of murine liver allograft recipients in response to granulocyte/ macrophage colony-stimulating factor. J Exp Med 182: 379-387.
-
(1995)
J Exp Med
, vol.182
, pp. 379-387
-
-
Lu, L.1
Rudert, W.A.2
Qian, S.3
-
28
-
-
0035073210
-
In vitro and in vivo induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene
-
Cheng SL, Lou J, Wright NM, et al. 2001. In vitro and in vivo induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene. Calcif Tissue Int 68:87-94.
-
(2001)
Calcif Tissue Int
, vol.68
, pp. 87-94
-
-
Cheng, S.L.1
Lou, J.2
Wright, N.M.3
-
29
-
-
0034815142
-
Opposite effects of bone morphogenetic protein-2 and transforming growth factor-betal on osteoblast differentiation
-
Spinella-Jaegle S, Roman-Roman S, Faucheu C, et al. 2001. Opposite effects of bone morphogenetic protein-2 and transforming growth factor-betal on osteoblast differentiation. Bone 29:323-330.
-
(2001)
Bone
, vol.29
, pp. 323-330
-
-
Spinella-Jaegle, S.1
Roman-Roman, S.2
Faucheu, C.3
-
30
-
-
33745016514
-
Gene-mediated osteogenic differentiation of stem cells by bone morphogenetic proteins-2 or -6
-
Zachos TA, Shields KM, Bertone AL. 2006. Gene-mediated osteogenic differentiation of stem cells by bone morphogenetic proteins-2 or -6. J Orthop Res 24:1279-1291.
-
(2006)
J Orthop Res
, vol.24
, pp. 1279-1291
-
-
Zachos, T.A.1
Shields, K.M.2
Bertone, A.L.3
-
31
-
-
29244462289
-
BMP2 gene therapy on the repair of bone defects of aged rats
-
Yue B, Lu B, Dai KR, et al. 2005. BMP2 gene therapy on the repair of bone defects of aged rats. Calcif Tissue Int 77:395-403.
-
(2005)
Calcif Tissue Int
, vol.77
, pp. 395-403
-
-
Yue, B.1
Lu, B.2
Dai, K.R.3
-
32
-
-
0141484485
-
HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells
-
Le Blanc K, Tammik C, Rosendahl K, et al. 2003. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 31:890-896.
-
(2003)
Exp Hematol
, vol.31
, pp. 890-896
-
-
Le Blanc, K.1
Tammik, C.2
Rosendahl, K.3
-
33
-
-
0141886188
-
Veto-like activity of mesenchymal stem cells: Functional discrimination between cellular responses to alloantigens and recall antigens
-
Potian JA, Aviv H, Ponzio NM, et al. 2003. Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens. J Immunol 171:3426-3434.
-
(2003)
J Immunol
, vol.171
, pp. 3426-3434
-
-
Potian, J.A.1
Aviv, H.2
Ponzio, N.M.3
-
34
-
-
0028937785
-
Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses
-
Yang Y, Li Q, Ertl HC, et al. 1995. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol 69:2004-2015.
-
(1995)
J Virol
, vol.69
, pp. 2004-2015
-
-
Yang, Y.1
Li, Q.2
Ertl, H.C.3
-
35
-
-
0028234357
-
In vivo correction of low density lipoprotein receptor deficiency inn the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses
-
Kozarsky KF, McKinley DR, Austin LL, et al. 1994. In vivo correction of low density lipoprotein receptor deficiency inn the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses. J Biol Chem 269:13695-13702.
-
(1994)
J Biol Chem
, vol.269
, pp. 13695-13702
-
-
Kozarsky, K.F.1
McKinley, D.R.2
Austin, L.L.3
-
36
-
-
0027521773
-
Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice
-
Smith TA, Mehaffey MG, Kayda DB, et al. 1993. Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nat Genet 5:397-402.
-
(1993)
Nat Genet
, vol.5
, pp. 397-402
-
-
Smith, T.A.1
Mehaffey, M.G.2
Kayda, D.B.3
-
37
-
-
0029790327
-
Prevention of immune reactions triggered by first-generation adenoviral vectors by monoclonal antibodies and CTLA4Ig
-
Guerette B, Vilquin JT, Gingras M, et al. 1996. Prevention of immune reactions triggered by first-generation adenoviral vectors by monoclonal antibodies and CTLA4Ig. Hum Gene Ther 7:1455-1463.
-
(1996)
Hum Gene Ther
, vol.7
, pp. 1455-1463
-
-
Guerette, B.1
Vilquin, J.T.2
Gingras, M.3
-
38
-
-
0032704286
-
Local adenovirus-mediated CTLA4-immunoglobulin expression suppresses the immune responses to adenovirus vectors in the brain
-
Ideguchi M, Kajiwara K, Yoshikawa K, et al. 2000. Local adenovirus-mediated CTLA4-immunoglobulin expression suppresses the immune responses to adenovirus vectors in the brain. Neuroscience 95:217-226.
-
(2000)
Neuroscience
, vol.95
, pp. 217-226
-
-
Ideguchi, M.1
Kajiwara, K.2
Yoshikawa, K.3
-
39
-
-
0031883333
-
Blunting of immune responses to adenoviral vectors in mouse liver and lung with CTLA4Ig
-
Jooss K, Turka LA, Wilson JM. 1998. Blunting of immune responses to adenoviral vectors in mouse liver and lung with CTLA4Ig. Gene Ther 5:309-319.
-
(1998)
Gene Ther
, vol.5
, pp. 309-319
-
-
Jooss, K.1
Turka, L.A.2
Wilson, J.M.3
-
40
-
-
0030984335
-
Transient immunomodulation with anti-CD40 ligand antibody and CTLA4Ig enhances persistence and secondary adenovirus-mediated gene transfer into mouse liver
-
Kay MA, Meuse L, Gown AM, et al. 1997. Transient immunomodulation with anti-CD40 ligand antibody and CTLA4Ig enhances persistence and secondary adenovirus-mediated gene transfer into mouse liver. Proc Natl Acad Sci USA 94:4686-4691.
-
(1997)
Proc Natl Acad Sci USA
, vol.94
, pp. 4686-4691
-
-
Kay, M.A.1
Meuse, L.2
Gown, A.M.3
-
41
-
-
0029113869
-
Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration
-
Kay MA, Holterman AX, Meuse L, et al. 1995. Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration. Nat Genet 11:191-197.
-
(1995)
Nat Genet
, vol.11
, pp. 191-197
-
-
Kay, M.A.1
Holterman, A.X.2
Meuse, L.3
-
42
-
-
0242684554
-
Efficient BMP2 gene transfer and bone formation of mesenchymal stem cells by a fiber-mutant adenoviral vector
-
Tsuda H, Wada T, Ito Y, et al. 2003. Efficient BMP2 gene transfer and bone formation of mesenchymal stem cells by a fiber-mutant adenoviral vector. Mol Ther 7:354-365.
-
(2003)
Mol Ther
, vol.7
, pp. 354-365
-
-
Tsuda, H.1
Wada, T.2
Ito, Y.3
|